dr. friedlander on checkpoint inhibitors in second-line bladder cancer treatment
Published 6 years ago • 282 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
1:44
dr. friedlander on checkpoint inhibitors in the second-line setting of bladder cancer
-
1:14
dr. plimack on second-line checkpoint inhibitors in bladder cancer
-
3:16
dr friedlander on the duravelo-2 trial for advanced or metastatic urothelial cancer
-
1:06
dr. o'donnell compares checkpoint inhibitors in bladder cancer
-
1:28
dr. flaig on immune checkpoint inhibitors in advanced bladder cancer
-
1:00
dr. apolo on toxicity challenges with checkpoint inhibitors in bladder cancer
-
32:30
bladder cancer and immunotherapy with dr. terence friedlander
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
32:44
nephrology: 1 diagnostic tests in nephrology conrad fischer
-
44:56
immune checkpoint blockade in cancer therapy
-
32:23
human prion diseases/creutzfeld-jacob disease - diagnosis and treatment - richard knight
-
0:56
dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
-
2:01
immune checkpoint inhibitors in urothelial bladder cancer
-
5:14
treatment of bladder cancer-immune checkpoint inhibitors
-
1:14
how can we continue the success of checkpoint inhibitors for bladder cancer treatment?
-
0:55
dr. plimack on frontline checkpoint inhibitors in bladder cancer
-
6:00
use of immune checkpoint inhibitors for bladder cancer
-
1:32
dr. apolo on managing toxicities of checkpoint inhibitors in bladder cancer
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
1:08
dr. inman on immunotherapy combinations in bladder cancer
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
1:21
dr. o’donnell on pd-l1 testing in bladder cancer